Business Description
Nanoviricides Inc
NAICS : 325412
SIC : 2834
ISIN : US6300872032
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.2 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | -0.2 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5 | |||||
3-Year EPS without NRI Growth Rate | 4.7 | |||||
3-Year FCF Growth Rate | 11.1 | |||||
3-Year Book Growth Rate | -28 | |||||
Future 3-5Y EPS without NRI Growth Rate | 20.46 |
Momentum Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 41.65 | |||||
9-Day RSI | 41.81 | |||||
14-Day RSI | 41.66 | |||||
6-1 Month Momentum % | 24.19 | |||||
12-1 Month Momentum % | 27.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.66 | |||||
Quick Ratio | 3.66 | |||||
Cash Ratio | 3.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.9 | |||||
Shareholder Yield % | -7.34 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -66.46 | |||||
ROA % | -59.24 | |||||
ROIC % | -104.49 | |||||
ROC (Joel Greenblatt) % | -105.97 | |||||
ROCE % | -63.03 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 1.41 | |||||
Price-to-Tangible-Book | 1.35 | |||||
EV-to-EBIT | -1.87 | |||||
EV-to-EBITDA | -2.06 | |||||
EV-to-FCF | -2.26 | |||||
Price-to-Net-Current-Asset-Value | 4.14 | |||||
Price-to-Net-Cash | 4.29 | |||||
Earnings Yield (Greenblatt) % | -53.5 | |||||
FCF Yield % | -31.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Nanoviricides Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.648 | ||
Beta | 0.87 | ||
Volatility % | 119.13 | ||
14-Day RSI | 41.66 | ||
14-Day ATR (€) | 0.07537 | ||
20-Day SMA (€) | 1.294 | ||
12-1 Month Momentum % | 27.27 | ||
52-Week Range (€) | 0.895 - 3.02 | ||
Shares Outstanding (Mil) | 14.68 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Nanoviricides Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Nanoviricides Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Nanoviricides Inc Frequently Asked Questions
What is Nanoviricides Inc(FRA:NV3P)'s stock price today?
When is next earnings date of Nanoviricides Inc(FRA:NV3P)?
Does Nanoviricides Inc(FRA:NV3P) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |